Rhumbline Advisers Merck & Co., Inc. Transaction History
Rhumbline Advisers
- $104 Billion
- Q1 2025
A detailed history of Rhumbline Advisers transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 4,492,983 shares of MRK stock, worth $347 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
4,492,983
Previous 4,492,983
-0.0%
Holding current value
$347 Million
Previous $403 Million
-0.0%
% of portfolio
0.39%
Previous 0.39%
Shares
32 transactions
Others Institutions Holding MRK
# of Institutions
3,891Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$19.5 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.3 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.3 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.6 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $195B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...